Foslevodopa + foscarbidopa

Status:

Red

Decision Date:

February 2023

Comments

RED: NICE TA934 Foslevodopa–foscarbidopa for treating advanced Parkinson’s with motor symptoms. NHSE commissioned (Decision - December 2023) 

Red Drug Classifications

• 1: Requiring specialist assessment to enable patient selection, initiation and ongoing treating

search again